0A5J Stock Overview
Manufactures and sells off-patent branded pharmaceutical products in Germany and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
Dermapharm Holding SE Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €36.15 |
| 52 Week High | €49.44 |
| 52 Week Low | €30.95 |
| Beta | 1.08 |
| 11 Month Change | 0.78% |
| 3 Month Change | 9.82% |
| 1 Year Change | -19.92% |
| 33 Year Change | -47.68% |
| 5 Year Change | n/a |
| Change since IPO | -27.56% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0A5J | GB Pharmaceuticals | GB Market | |
|---|---|---|---|
| 7D | 1.0% | -1.9% | -1.0% |
| 1Y | -19.9% | 9.8% | 7.3% |
Return vs Industry: 0A5J underperformed the UK Pharmaceuticals industry which returned 9.8% over the past year.
Return vs Market: 0A5J underperformed the UK Market which returned 7.3% over the past year.
Price Volatility
| 0A5J volatility | |
|---|---|
| 0A5J Average Weekly Movement | 4.1% |
| Pharmaceuticals Industry Average Movement | 7.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.1% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: 0A5J has not had significant price volatility in the past 3 months.
Volatility Over Time: 0A5J's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 3,497 | Hans-Georg Feldmeier | ir.dermapharm.de |
Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany and internationally. It operates through three segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts. The company develops, manufactures, licenses, markets, and sells branded generics, over-the-counter drugs, non-prescription healthcare products, herbal extracts, and other pharmaceutical products.
Dermapharm Holding SE Fundamentals Summary
| 0A5J fundamental statistics | |
|---|---|
| Market cap | €1.94b |
| Earnings (TTM) | €56.58m |
| Revenue (TTM) | €1.13b |
34.3x
P/E Ratio1.7x
P/S RatioIs 0A5J overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0A5J income statement (TTM) | |
|---|---|
| Revenue | €1.13b |
| Cost of Revenue | €438.33m |
| Gross Profit | €690.97m |
| Other Expenses | €634.38m |
| Earnings | €56.58m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 14, 2024
| Earnings per share (EPS) | 1.05 |
| Gross Margin | 61.19% |
| Net Profit Margin | 5.01% |
| Debt/Equity Ratio | 175.3% |
How did 0A5J perform over the long term?
See historical performance and comparisonDividends
2.4%
Current Dividend Yield84%
Payout RatioDoes 0A5J pay a reliable dividends?
See 0A5J dividend history and benchmarks| Dermapharm Holding dividend dates | |
|---|---|
| Ex Dividend Date | Jun 28 2024 |
| Dividend Pay Date | Jul 02 2024 |
| Days until Ex dividend | 1 day |
| Days until Dividend pay date | 3 days |
Does 0A5J pay a reliable dividends?
See 0A5J dividend history and benchmarks